powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1396087342
Beth Zha
M.D., PH.D.
Pulmonary Disease
San Francisco,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
744
Unique beneficiaries
—
Total services
951
Distinct HCPCS
16
Medicare payment
$44K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 901 Pulmonary Disease providers in CA — above median (cohort median 927).
PRESCRIBING · PART D · 2024
Total Rx claims
1,105
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
26
Brand share
68.8%
Top prescribed drugs
Albuterol Sulfate
146 claims
Umeclidinium Brm/Vilanterol Tr
132 claims
Tiotropium Br/Olodaterol Hcl
88 claims
Azithromycin
81 claims
Tiotropium Bromide
53 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
95.0
Cost
80.6
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$5K
Payment records
6
By payment type
Consulting Fee
$5K
Food and Beverage
$149